Siegfried has inaugurated a new large-scale production facility for the manufacture of active pharmaceutical ingredients (APIs) at its site in Minden, Germany.
The facility expands reactor capacity by 100 m³ and strengthens Siegfried's position as one of the world's leading CDMOs for small-scale pharmaceuticals.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Siegfried has inaugurated a new large-scale production facility for the manufacture of active pharmaceutical ingredients (APIs) at its site in Minden, Germany.
The facility expands reactor capacity by 100 m³ and strengthens Siegfried's position as one of the world's leading CDMOs for small-scale pharmaceuticals.